After a decade of stonewalling injured patients complaints about adverse reactions to LASIK vision-therapy laser surgeries, CDRH lifts their hopes for...
Federal Register notice: FDA corrects an incorrect docket number appearing in a 9/11 Federal Register notice entitled Post-approval Changes to Drug Su...
FDA issues one draft and two final guidances explaining provisions of the Drug Supply Chain Security Act relating to drug product identifiers.
Attorney Anne Walsh says the Justice Department has directed its civil litigators to oppose court attempts to impose nationwide injections, including ...
CDER issues a Manual of Policies and Procedures on establishing drug substance and drug product impurity acceptance criteria for NDAs, ANDAs, and BLAs...
Arca Biopharma submits a special protocol assessment request for its planned Phase 3 clinical development program of Gencaro (bucindolol hydrochloride...
FDA issues a Pharming Group complete response letter on its supplemental BLA for Ruconest [C1 esterase inhibitor (recombinant)] to expand the current ...
AdvaMed gives FDA recommendations for ways to reduce risk in pediatric medical device development.